Exovisse Preservative-free Artificial Tears Liquid
NDC Package 87106-005-01
Package Information
Exovisse Preservative-free Artificial Tears (lubricant eye gel drops) liquids is usesFor the temporary relief of burning and irritation due to dryness of the eye For use as a protectant against further irritation. This formulation utilizes a liquid delivery system. Marketed by Yd Bio Usa, Inc., this product is identified by NDC 87106-005 and is authorized under FDA application M018.
Identification & Billing
- RxCUI: 2723485 - hypromellose 0.2 % Ophthalmic Gel
- RxCUI: 2723485 - hypromellose 0.002 MG/MG Ophthalmic Gel
Clinical Specifications
- Ophthalmic - Administration to the external eye.
- Ophthalmic - Administration to the external eye.
Regulatory & Marketing
Hierarchy Structure
- 87106 - Yd Bio Usa, Inc.
- 87106-005 - Exovisse Preservative-free Artificial Tears
- 87106-005-01 - 1 BOTTLE, DROPPER in 1 CARTON / .5 mL in 1 BOTTLE, DROPPER
- 87106-005 - Exovisse Preservative-free Artificial Tears
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (87106-005). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 87106-005-01 identifies a specific commercial package of 1 bottle, dropper in 1 carton / .5 ml in 1 bottle, dropper of Exovisse Preservative-free Artificial Tears, a human over the counter drug labeled by Yd Bio Usa, Inc.. This liquid is formulated for ophthalmic use and contains hypromelloses as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Yd Bio Usa, Inc. on April 05, 2026. The current certification is valid through December 31, 2027.
How is this Yd Bio Usa, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 87106000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.